CompletedNCT05631626
Phase 3 Efficacy and Safety Study in Adults With ADHD Using CTx-1301.
This study is completed in the United States. It focuses on ADHD.
In Las VegasADHDDrugA study involving a medication or substance.From 18 Years to 55 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT00556296
Study of NRP104 in Children Aged 6-12 With ADHD
This study is completed. It is testing NRP104 for ADHD.
Location not clearly listedADHDDrugFrom 6 Years to 12 Years
Enrolling By InvitationNCT07095465
Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis
This study is enrolling by invitation in the United States, in Bulgaria, and in Czechia. It is testing ACP-204 for Schizophrenia.
Multiple locations, including IrvineSchizophreniaDrugFrom 55 Years to 84 Years
CompletedNCT00761605
Phase 4 Study to Evaluate Efficacy of Paliperidone Extended-Release(ER) in Schizophrenic Participants
This study is completed in South Korea. It is testing Efficacy of Paliperidone Extended-Release(ER) for Schizophrenia.
Multiple locations, including ChunchunSchizophreniaDrugFrom 18 Years to 65 Years
TerminatedNCT03143543
Phase I Functional Magnetic Resonance Imaging (fMRI) Pharmacodynamic Studies of Compounds for Addiction and Addiction
This summary needs review. Please check the official study record and contact the research team for details.
In RichmondAddictionDrugFrom 18 Years to 55 Years
CompletedNCT02286817
NFC-1 for ADHD
This study is completed in the United States. It is testing NFC-1 for ADHD.
In PhiladelphiaADHDDrugFrom 12 Years to 17 Years
CompletedEUCTR 2007-001216-23
Phase I Studie bei substituirten chronischen Opiatgebrauchern zur Aufhebung zusätzlicher Opioidwirkungen einer weiteren Opiatgebrauchern zur Aufhebung zusätlicher Opioidwirkungen einer weiteren Opi...
This study is completed in Austria. It focuses on Addiction.
In AustriaAddictionOther
CompletedNCT02023606
Phase I Study to Assess the Absorption, Metabolism, and Excretion of [14C] Labeled SPN-810M
This study is completed in the United Kingdom. It focuses on ADHD.
In RuddingtonADHDDrugFrom 30 Years to 55 Years
TerminatedNCT01851603
Safety study of Safety and Pharmacokinetics of Oral Doses of Anvylic-3288 in Schizophrenia
This study was terminated in the United States. It is testing Safety and Pharmacokinetics of Oral Doses of Anvylic-3288 for Schizophrenia.
In AuroraSchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 70 Years
CompletedNCT01672684
Phase I: At-Home Support for Rural Women Using Group Video Calling
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Nevada CityPTSD, DepressionBehavioralOver 21 Years
CompletedNCT05976646
Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion
This summary needs review. Please check the official study record and contact the research team for details.
In RichmondAddictionBehavioralFrom 18 Years to 65 Years
CompletedNCT00365209
Phase II A study of Curcumin Among people with Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci)
This summary needs review. Please check the official study record and contact the research team for details.
In OrangeAddictionOtherOver 40 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.